Immunohistochemical characteristics of renal cell carcinoma with intravenous extension

Immunohistochemical characteristics of renal cell carcinoma with intravenous extension

Up to this day, there is still no sufficient data on immunohistochemical characteristics of intravenous neoplastic thrombi, as well as there is still no general theory about their formation process. Aim. In order to clarify the pathogenesis of macroscopic intravenous proliferation of renal cell c...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. V. Shchukin, I. I. Yakovtsova, V. N. Lesovoy, S. V. Danyluk, M. N. Babich, V. D. Tovazhnyanska, V. N. Demchenko
Format:	Article
Language:	English
Published:	Zaporizhzhia State Medical and Pharmaceutical University 2015-04-01
Series:	Patologìâ
Subjects:	Renal Cell Carcinoma Thrombosis Matrix Metalloproteinase 9 Immunohistochemistry
Online Access:	http://pat.zsmu.edu.ua/article/view/42930/39318
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative characteristic of methods for determining the inflammation marker matrix metalloproteinase-9
by: E. V. Baranova, et al.
Published: (2014-12-01)

Comparative analysis of content of the matrix metalloproteinase-9 in patients with acute cerebral strokes of different types
by: E. V. Baranova
Published: (2014-10-01)

The content of matrix metalloproteinase-1, -9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity
by: V. V. Kachkovska, et al.
Published: (2023-12-01)

Local proteolytic system indicators as suspective factors of keratolysis development after urgent keratoplasty
by: E. V. Chentsova, et al.
Published: (2024-07-01)

Specific immunohistochemical expression of Mmp-26 in prostatic adenocarcinoma
by: ROMILDO LUCIANO DA SILVA, et al.
Published: (2025-01-01)

Matrix metalloproteinase 9, superoxide dismutase and lipid peroxidation in preterm newborns with perinatal hypoxia
by: Yu. V. Korenovsky, et al.
Published: (2011-04-01)

Matrix metalloproteinase-9, its inhibitor-1 and interleukines in experimental traumatic brain injury
by: S. V. Ziablitsev, et al.
Published: (2016-12-01)

Assessment of Matrix Metalloproteinases a Prognostic Indicator in Advanced Fibrotic Lung Disease: A Systematic Review
by: Mehvish Aqil, et al.
Published: (2025-04-01)

Correlation between markers of fibrosis and myocardial remodeling in patients with various course of hypertrophic cardiomyopathy
by: F. M. Bogatyreva, et al.
Published: (2022-03-01)

Gelatinases A and B activities in the serum of patients with various coronary artery disease stages
by: Radenković Sandra, et al.
Published: (2010-01-01)

Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
by: A. O. Rubanenko, et al.
Published: (2018-11-01)

Relationships between MMP-2, MMP-9, and ADAMDEC1 serum and tissue levels in patients with colorectal cancer
by: Zahra Mozooni, et al.
Published: (2025-04-01)

Influence of diuretics with antialdosterone effect on the condition of extracellular matrix and early postinfarction remodeling of the left ventricle in patients with Q-wave myocardial infarction
by: S. M. Kyselov
Published: (2015-08-01)

Expression of MMP-2, MMP-9 and TIMP-2 in pituitary tumors and their relationship with cavernous sinus invasion
by: Ane Caroline Thé B Freire, et al.
Published: (2025-01-01)

Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
by: K. P. Lactionov, et al.
Published: (2014-07-01)

Parameters of the mmp / timp system in assessing the clinical course of pulmonary tuberculoma
by: D. S. Esmedlyaeva, et al.
Published: (2024-04-01)

Investigation of the Neuroprotective Effect of Riluzole on Matrix Metalloproteinases in an Experimental Model of Glaucoma
by: Fatma Yildiz, et al.
Published: (2024-04-01)

Gender peculiarities and prognostic value of matrix metalloproteinase and their inhibitors system in patients with acute Q-wave left ventricle myocardial infarction
by: S. M. Kyselov
Published: (2015-02-01)

Changes in the extracellular matrix under the influence of anticoagulant therapy in patients with Q-myocardial infarction after thrombolysis
by: S. M. Kyselov
Published: (2014-12-01)

Role of Gene Polymorphisms of Matrix Metalloproteinases-2, -3 and -13 in the Development of Coronary Artery Atherosclerosis in Patients with Primary Polyosteoarthrosis
by: O. O. Portyannikova, et al.
Published: (2020-03-01)

Matrix metalloproteinase-3 is a potent prognostic factor associated with cell proliferation and migration in prostate cancer
by: Ai Sato, et al.
Published: (2025-03-01)

Content of matrix metalloproteinases in the blood of hypertensive patients with a high cardiovascular risk receiving statin therapy
by: V. P. Mikhin, et al.
Published: (2022-11-01)

Complex studies on gene polymorphisms of MMP2, MMP3, MMP9 matrix metalloproteinases and TIMP1, TIMP2 tissue inhibitors of metalloproteinases in the patients with primary open-angle glaucoma
by: A. V. Shevchenko, et al.
Published: (2023-04-01)

Clinical significance of matrix metalloproteinase (MMP)-2 and MMP-9 expression in laryngeal squamous cell carcinoma
by: Rašić Dejan, et al.
Published: (2021-01-01)

Immunohistochemical Study of Laminin-332 γ2 Chain and MMP-9 in High Risk of Malignant Transformation Oral Lesions and OSCC
by: Eline Manhães Reid Silva, et al.
Published: (2018-03-01)

The predictive function of rates of matrix metalloproteinases/inhibitors system when assessing reparative changes in the lung tissue in those with infiltrate pulmonary tuberculosis
by: D. S. Esmedlyaevа, et al.
Published: (2018-10-01)

Features of the level of matrix metalloproteinase-2, -3, -9 and tissue inhibitors of metalloproteinases-1, -2, -3, -4 in the aqueous humor of patients with primary open-angle glaucoma
by: V. V. Chernykh, et al.
Published: (2022-01-01)

Matrix metalloproteinase system in blood serum in patients with squamous cell head and neck carcinomas
by: Ye. V. Klisho, et al.
Published: (2011-02-01)

Plasma Markers of Degradation of Extracellular Matrix with Intrauterine Herpes Infection
by: S. N. Beniova, et al.
Published: (2016-11-01)

Comparison of Inflammatory Biomarkers in Females with and Without Patellofemoral Pain and Associations with Patella Position, Hip and Knee Kinematics, and Pain
by: Lori A. Bolgla, et al.
Published: (2025-03-01)

The relevance applying in the adhesive protocol in devital teeth
by: Z. S. Khabadze, et al.
Published: (2021-05-01)

DYNAMICS OF FIBROSIS MARKERS ON THE BACKGROUND OF TB/HIV CO-INFECTION TREATMENT
by: Olga SHEVCHENKO, et al.
Published: (2025-04-01)

Single nucleotide substitutions in the matrix metalloproteinase 9 gene in hypertensive individuals of European and South Asian ethnicity in the Far Eastern Federal District
by: N. G. Plekhova, et al.
Published: (2022-01-01)

The levels of hypoxia- and angiogenesis-related regulators and matrix metalloproteinase 9 activity in tear fluid of patients with non-penetrating ocular traumas
by: I.V. Gavrylyak, et al.
Published: (2022-12-01)

The concentration of matrix metalloproteinase 9 in the tumor and peritumoral tissue as prognostic marker in breast cancer patients
by: Cvetković Danijela M., et al.
Published: (2019-01-01)

Expression of matrix metalloproteinases 2, 7 and 9 in patients with colorectal cancer
by: Kostova Elena, et al.
Published: (2014-01-01)

Activity of matrix metalloproteinases and their tissue inhibitors in serum in chronic granulating periodontitis
by: D. I. Haidash, et al.
Published: (2019-12-01)

Role of type IV collagen and matrix metalloproteinase-9 in remodeling of the left ventricular in coronary artery disease
by: M. A. Popov, et al.
Published: (2019-09-01)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 expression is upregulated in congenital lung malformations
by: Ayşe Parlak, et al.
Published: (2025-02-01)

Pygopus 2 promotes kidney cancer OS-RC-2 cells proliferation and invasion in vitro and in vivo
by: Rongfu Liu, et al.
Published: (2015-07-01)